Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, J. L.
Right arrow Articles by Levin, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, J. L.
Right arrow Articles by Levin, M. S.

The Journal of Nutrition Vol. 127 No. 7 July 1997, pp. 1297-1303
Copyright ©1997 by the American Society for Nutritional Sciences

Retinoic Acid Stimulates Early Cellular Proliferation in the Adapting Remnant Rat Small Intestine after Partial Resection1,2,3

Joseph L. Wang, Deborah A. Swartz-Basile, Deborah C. Rubin, and Marc S. Levin4

Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
ACKNOWLEDGMENTS
FOOTNOTES
LITERATURE CITED


ABSTRACT

Following loss of small bowel surface area, the remnant intestine undergoes a remarkable adaptive response. To define more fully the underlying molecular mechanisms, we have identified genes that are specifically induced in the adapting remnant after partial small bowel resection. Several of these, including cellular retinol binding protein II (CRBP II) and apolipoprotein (apo) AI, participate in vitamin A and lipid trafficking. The CRBP II and apo A-I promoters contain response elements for the nuclear retinoid X receptor RXR-alpha . It is well established that vitamin A is essential for normal cell growth, differentiation and maintenance of epithelial tissues and that CRBP II functions to facilitate intestinal vitamin A absorption and metabolism. On the basis of these considerations, changes in CRBP II and apo A-I mRNA levels could reflect a role for retinoids in modulating the intestinal adaptive response. To explore this hypothesis, we used a rat resection model of intestinal adaptation to examine the temporal patterns of CRBP II, apo A-I and RXR-alpha expression postresection. CRBP II and apo A-I mRNA levels were increased in the remnant intestine in distinct temporal patterns, whereas RXR-alpha expression was unchanged. To address directly the effects of vitamin A in adaptation, retinoic acid or vehicle was administered intravenously to rats immediately after 70% small bowel resection. Compared with vehicle, all-trans-retinoic acid significantly stimulated crypt cell proliferation in the adapting remnant intestine by 6 h after surgery. These data suggest that retinoic acid acts to modulate intestinal proliferation in the adapting small intestine after loss of functional small bowel surface area.

KEY WORDS: intestinal adaptation · retinoids · cellular retinol binding protein II · apolipoprotein AI bullet rats


INTRODUCTION

The small intestine is able to compensate for the loss of functional surface area. This adaptive response is characterized by distinctive morphological changes that are associated with enhanced absorptive capacity. Enhanced crypt cell proliferation leads to crypt hyperplasia and increased crypt depth [reviewed in Hanson (1982)]. Villus lengthening also occurs and, as we have recently shown, villus enterocytes directly contribute to the early adaptive response by augmenting synthesis of a variety of cellular mRNA and proteins (Rubin et al. 1996). Although enteral nutrients are necessary for these adaptive changes to occur, little is known about the specific extracellular mediators and intracellular mechanisms required for full expression of the adaptive response [reviewed in Saxena et al. (1993)]. Identification of these should suggest strategies for augmenting the adaptive response that would benefit patients dependent on parenteral nutrition such as those with short bowel syndrome resulting from Crohn's disease.

As an approach to defining the molecular mechanisms underlying the adaptive response, we have used subtractive hybridization cloning techniques to identify genes that are differentially regulated in the adapting rat intestine 48 h after 70% resection (Dodson et al. 1996). One group of cDNA clones induced during intestinal adaptation includes cellular retinol binding protein II (CRBP II),5 liver fatty acid binding protein, ileal lipid binding protein and apolipoprotein (apo) AIV. All of these encode proteins involved in the absorption, metabolism and trafficking of fatty acids, lipids or retinoids. Induction of these genes in the early adaptive period may occur to augment assimilation of these nutrients specifically or to regulate or modulate the adaptive response.

The latter possibility is most likely for CRBP II. This abundant small intestinal retinol and retinal binding protein plays an essential role in intestinal vitamin A trafficking [reviewed in Levin (1994)]. For example, the magnitude of retinol absorption, esterification with long-chain fatty acids and the secretion of retinyl esters correlate with cellular levels of CRBP II (Levin 1993, Lissoos et al. 1995). Retinol and its metabolites, including retinoic acid, are essential for normal embryogenesis, cell growth and differentiation, and maintenance of epithelial tissues. These functions are thought to be mediated through binding of retinoids to retinoid nuclear receptors. Homo- and heterodimeric receptor complexes modulate the transcription of target genes containing retinoic acid receptor response elements [reviewed in Chambon (1996)]. The retinoid receptors that have been identified include the retinoic acid receptors and retinoid X receptors (RXR). Retinoic acid receptors are activated by all-trans- and 9-cis-retinoic acid, whereas RXR bind exclusively to 9-cis-retinoic acid.

Retinoid receptor response elements have been identified in the CRBP II promoter (Mangelsdorf et al. 1991, Nakshatri and Chambon 1994), and we have demonstrated that retinoic acid regulates CRBP II expression in the human intestinal cell line, Caco-2 (Levin and Davis 1997). Thus, the increased expression of CRBP II in the remnant ileum postresection suggests a regulatory role for retinoids in the adaptive process. Furthermore, it is possible that changes in CRBP II levels after partial small intestinal resection could directly affect intestinal gene expression (and thus the adaptive process) by modulating the synthesis and nuclear delivery of all-trans- and 9-cis-retinoic acid.

To address these issues, we compared the expression patterns of CRBP II and apo A-I, an enterocytic gene that also has an RXR-alpha response element in its promoter [reviewed in Kardassis et al. (1996)]. We observed that the temporal pattern of CRBP II expression in the remnant intestine after partial resection was distinct from that of apo A-I and the fatty acid binding proteins. These results are consistent with the hypothesis that retinoids may play a unique role in the initiation and/or maintenance of the adaptive response. Furthermore, our analysis of the effects of in vivo retinoic acid administration on crypt cell proliferation in the remnant ileum after 70% small bowel resection, indicates that retinoids may modulate the early intestinal adaptive response by stimulating crypt cell proliferation.


MATERIALS AND METHODS

Surgical procedures and tissue harvesting. Male Sprague-Dawley rats weighing 220-250 g (Sasco, Omaha, NE) were acclimated in the animal care facility for at least 72 h before surgery. Rats were housed under strict day and night light cycles with free access to water and Teklad 7001 4% standard laboratory rat nonpurified diet (Teklad 7001, Harlan Teklad, Madison, WI). Food was withheld for 12 h before surgery and operations were performed between 0600 and 1100 h. Pentobarbital (40 mg/kg, intraperitoneal), atropine (0.4 mg/kg) and inhalational metofane were administered for anesthesia. Experimental rats underwent 70% small intestinal resection. After a midline abdominal incision, the small intestine from 5 cm distal to the ligament of Treitz to 15 cm proximal to the ileo-cecal valve was resected and the remnant small intestine was reanastomosed end to end using 6-0 silk interrupted sutures. Control rats, paired by weight with experimental rats, underwent a single transection at 5 cm distal to the ligament of Treitz followed by reanastomosis without bowel resection. All rats received gentamicin (4 mg in 6 mL normal saline) intraperitoneally at the time of abdominal wall closure. Rats had free access to water containing sucrose (50 g/L) and oxytetracycline (4.5 g/L) for 24 h postsurgery and then to nonpurified diet.

Tissues (n = 3-10 rats per group per time point) were harvested at 2, 4, 8, 16, 24 and 48 h and at 1 wk following surgery for the time course studies. For all studies, rats were killed by sodium pentobarbital overdose (150 mg/kg, intraperitoneal). The intestines were divided into duodenal and jejunal segments (i.e., intestine proximal to the anastomosis) and three 5-cm ileal segments (proximal, mid- and distal) starting 15 cm proximal to the ileocecal valve. The protocols for all animal studies were reviewed and approved by the Washington University Animal Studies Committee.

Retinoic acid administration. Stock solutions of all-trans-retinoic acid (Sigma, St. Louis, MO) were prepared in 100% ethanol, purged with N2 and handled on ice in red light (60 W) or dim lighting. The purity and concentration were assessed by absorbance spectrophotometry. To evaluate the effects of retinoic acid on the adaptive process, 18 µg (~0.08 mg/kg) or 100 µg (~0.44 mg/kg) all-trans-retinoic acid or vehicle only was injected into the tail vein of resected rats immediately after surgery. Each 500-µL injection was composed of 100 µL of a retinoic acid stock solution or 100 µL of ethanol (vehicle control) plus 400 µL of PBS. At 6 and 16 h after resection, 3-9 rats per group were killed and tissues were harvested as described above, except that the ileum was not subdivided. The effects of retinoic acid administration were also studied without partial small bowel resection. For these studies, unoperated rats were treated with retinoic acid (18 or 100 µg) or the vehicle and killed after 6 or 16 h.

RNA analysis. Total cellular RNA was extracted from full-thickness intestinal sections, fractionated by denaturing gel electrophoresis and transferred to nylon membranes (Micron Separation, Westboro MA) or supported nitrocellulose membranes (GibcoBRL Life Technologies, Gaithersburg, MD) as described (Rubin et al. 1996). RNA dot blot hybridization techniques were used to assess postresection temporal patterns of ileal CRBP II, apo A-I and RXR-alpha expression after intestinal resection or sham surgery, as previously described (Levin et al. 1987, Rubin et al. 1989). Only RNA samples confirmed to be intact by denaturing gel electrophoresis were used for constructing dot blots. For these studies, the remnant ilea and equivalent control ilea from sham-operated rats were divided into three equal segments. Segmental pools of RNA were obtained from at least three rats per time point.

Northern blots were hybridized to assess the effect of retinoic acid administration on CRBP II, apo A-I and RXR-alpha mRNA levels. RNA samples from the combined duodenal-jejunal segment and from the ileal segments were analyzed for each experimental and control animal.

Rat CRBP II (Li et al. 1986), rat apo A-I (Elshourbagy et al. 1985) and RXR-alpha (Gearing et al. 1993, courtesy of E. Widmark and J. Gustaffsson, Karolinska Institute, Huddinge, Sweden) cDNAs were labeled with [alpha 32P]dCTP to high specific activity and the blots were hybridized at 42°C for 20 h (CRBP II and apo A-I) or 48 h (RXR-alpha ) and then washed as described (Levin et al. 1987). The stringency of these hybridization and washing conditions was confirmed to be specific for each of the study genes by Northern blot hybridization. For each cDNA, a single band of appropriate size was noted on Northern blots.

Densitometric quantitative analysis was used to compare expression in experimental resected rats and control sham-resected rats. Dot blots were quantitated by scanning laser densitometry (Levin et al. 1987, Rubin et al. 1989) and Northern blots by NIH Image 1.55 (W. Rasband, National Institute of Mental Health) analysis of digitized images obtained with a UMAX PS-2400X scanner using UMAX Magicscan V1.2 (UMAX Technologies, Fremont, CA). The relative magnitude of ileal expression of the study genes was the same in the proximal, mid- and distal segments. Thus, for statistical analyses of changes in ileal gene expression in the remnant ileum, data obtained from each of these segments were treated as a representative sample of total ileal RNA. All Northern blots were stripped and rehybridized with radiolabeled human glyceraldehyde 3-phosphate dehydrogenase (Tso et al. 1985) to correct for differences in RNA loading and transfer efficiency. This human cDNA hybridizes with rat RNA, producing a single band on Northern blot (data not shown). Levels of intestinal glyceraldehyde 3-phosphate dehydrogenase expression were not modified by intestinal resection or by retinoic acid or vehicle administration.

Immunohistochemical analysis. Intestinal segments were pre-fixed in Bouin's solution, and were embedded in paraffin or OCT compound (Miles, Elkhart, IN). Sections (5-6 µm) from resected and sham-resected rats were placed on the same slide for comparative analyses. CRBP II was detected using a polyclonal rabbit anti-rat antibody [1:200 dilution; courtesy of E. Li, Washington University, St. Louis MO (Levin 1993, Rubin et al. 1989)]. Antigen-antibody complexes were detected by immunogold staining with silver enhancement (Rubin et al. 1992). Photomicrographs were taken with a Nikon, (Japan) Microphot FX microscope.

Crypt cell proliferation. 5-Bromodeoxyuridine (5-BrdU) incorporation into DNA was used to measure crypt cell proliferation in rats that received retinoic acid or vehicle following small intestinal resection. 5-BrdU (8 g/L; Sigma) and 5-fluorodeoxyuridine (0.8 g/L, Sigma) combined in sterile water were injected intraperitoneally 90 min before rats were killed (final dose of 5-BrdU = 120 mg/kg). Tissue sections were incubated in 4 mol/L HCl for 30 min at room temperature to enhance antigen exposure. 5-BrdU was detected with a goat anti-BrdU antibody (1:5000, courtesy of S. Cohn, Washington University, St. Louis, MO). Antigen-antibody complexes were labeled using a gold-conjugated rabbit anti-goat secondary antibody with silver enhancement (Amersham Life Sciences, Arlington Heights, IL) or CY3-labeled donkey anti-goat IgG (Jackson Laboratories, Bar Harbor, ME). The number of labeled and unlabeled cells in 10 well-oriented, longitudinal crypts per segment from each rat (n = 5-9 rats per experimental group) was counted as described (Przemioslo et al. 1995) using light microscopy by an observer who had no knowledge of the identity of the slides. The labeling index is defined as the fraction of crypt cells incorporating 5-BrdU.

Statistical analysis. Individual experiments were designed to optimize detection of differences between the experimental and control groups at a given time postoperation or in response to a given dose of retinoic acid. Therefore, RNA and crypt cell proliferation data were analyzed by Student's t test for paired samples. The studies were not designed to quantitatively describe the expression of each gene in the two surgical groups as a function of time postoperatively or as a function of retinoic acid dose. However, the relative level of expression (i.e., fold increase) between sham and resected rats as a function of time or retinoic acid dose was amenable to analysis with a one-way ANOVA. Analyses were performed using Excel Version 5.0 (Microsoft, Seattle WA). Differences were considered significant at the P < 0.05 level.


RESULTS

Changes in CRBP II and apo A-I expression are not correlated after massive small bowel resection. Temporal patterns of CRBP II, apo A-I and RXR-alpha expression were determined after 70% small bowel resection or sham resection. Compared with controls, ileal CRBP II mRNA levels were increased by 8 h postresection and were still elevated at 1 wk (Fig. 1). The maximal increase (2.3-fold) occurred between 16 and 24 h. In contrast, the relative expression of apo A-I, which was also maximized at 16 h (1.7-fold increase), returned to control levels by 24 h (Fig. 1). Thus, the postresection temporal patterns of CRBP II and apo A-I expression were different. Compared with sham-resected controls, ileal RXR-alpha mRNA levels were not changed by intestinal resection at any of the time points examined (Fig. 1). Thus, transcriptional regulation of RXR-alpha does not precede the postresection changes in CRBP II and apo A-I mRNA levels.
Fig. 1. Relative changes in ileal cellular retinol binding protein II (CRBP II), apolipoprotein A-I (apo A-I), and retinoid X receptor (RXR)-alpha mRNA levels in 70% small bowel resected rats compared with sham resected are different. Rats were divided into seven groups of 6-20. Within each group, rats paired by weight underwent 70% small intestinal resection or sham resection. At the times indicated, groups of rats were killed and ileal RNA was isolated and used to prepare RNA dot blots. The blots were hybridized with radiolabeled cDNA as described in Materials and Methods. Ileal CRBP II, Apo A-I, and RXR-alpha mRNA levels were determined by quantitation of autoradiographs as described. The data shown at each of the indicated time points are the relative mRNA levels, which are the ratios of mRNA levels from resected rats to mRNA levels from comparable segments in sham-resected rats, expressed as means ± SEM (n = 3 pools of RNA from 3-10 rats using different portions of the ileal samples). *P <=  0.05, by Student's t test comparison of mRNA levels in the remnant ileum from resected rats to levels in the ileum from sham-resected rats.
[View Larger Version of this Image (29K GIF file)]

The expression of the CRBP II and apo A-I genes was two- to fivefold higher in the proximal small bowel (duodenal/jejunal segment) than in the ileum, consistent with maintenance of the normal cephalo-caudad gradient in expression of these genes (Rubin et al. 1989). However, CRBP II and apo A-I mRNA levels were not significantly increased in this segment by partial intestinal resection (data not shown).

Cell-specific patterns of CRBP II protein expression are preserved in adapting remnant ileum. Cellular patterns of CRBP II protein expression in the remnant adaptive gut were assessed using immunohistochemical techniques. CRBP II is normally expressed in villus enterocytes, but not in crypt cells (Crow and Ong 1985). The cell-specific patterns of expression of ileal CRBP II are preserved after sham-resection surgery or 70% massive small bowel resection (i.e., CRBP II is present in villus enterocytes located from the base of the villus to the tip, but not in crypt cells; Fig. 2). As indicated in Figure 2, the intensity of CRBP II immunostaining per enterocyte was greater in the resected compared with the sham-resected sections (compare Fig. 2A with 2B and Fig. 2C with 2D).
Fig. 2. Immunohistochemical analysis of CRBP II expression in the rat ileal epithelium after 70% small bowel resection. Multiple fields on four slides from the ileum of each of two rats per experimental group were analyzed for CRBP II expression. Representative sections are presented from rats killed 24 h (A, B) or 1 wk (C, D) after sham operation (A, C) or 70% small intestinal resection (B, D). CRBP II expression was detected using a monospecific polyclonal rabbit anti-rat CRBP II antibody and immunogold-silver staining techniques. In all sections, CRBP II is expressed in the cytoplasm of villus-associated enterocytes (black stained cells, large arrows) and is absent in the crypts (arrowheads indicate cytoplasm of crypt cells that do not express CRBP II, small arrows indicate hematoxylin-stained nuclei). A-B, ×200; C-D, ×125.
[View Larger Version of this Image (127K GIF file)]

Retinoic acid enhances cellular proliferation in the adapting remnant ileum after 70% small bowel resection. The early increase in expression of CRBP II and apo A-I in the residual intestine after massive small bowel resection suggests that retinoids may be important in initiating and/or maintaining the early adaptive response. To address this directly, we examined the effects of peri-operative retinoic acid administration on the adaptive response at 6 and 16 h postresection. Both of these time points preceded the reintroduction of the nonpurified diet and dietary vitamin A. These time points were chosen to examine the effect of retinoic acid on adaptive cellular proliferation early after resection. The 6-h time point also permitted an assessment of the effect of retinoic acid on basal expression of CRBPII and apo AI (i.e., before the usual postresection increase in CRBP II and apo A-I mRNA levels occurs). The 16-h time point was also chosen to determine whether CRBPII and apo AI expression could be further increased by retinoic acid administration (i.e., at 16 h, both genes are maximally increased in the remnant ileum compared with the control ileum).

The ability of the small intestinal epithelium to rapidly acquire and metabolize plasma-derived all-trans-retinoic acid is well established (Cullum and Zile 1985, Zile et al. 1982). Thus, to minimize dosage effects resulting from differences in absorptive capacity or efficiency, retinoic acid was administered intravenously upon completion of resection surgery. Two doses of retinoic acid were studied because plasma clearance deviates from first-order kinetics dose dependently and relative plasma concentrations of different retinoic acid metabolites vary dose dependently (Swanson et al. 1981). The 18-µg dose is thought to be "physiologic" and the 100-µg dose is well below "pharmacological" amounts (2-3 mg) used in many studies of retinoic acid metabolism [for examples see Cullum and Zile (1985), Swanson et al. (1981), Zile et al. (1982)].

To assess the ability of retinoic acid to stimulate ileal crypt cell proliferation postresection, 5-BrdU incorporation into DNA was quantitated. Representative tissue sections demonstrating 5-BrdU immunostaining in ileal segments of control (vehicle-treated) and retinoic acid-treated resected rats are shown in Figure 3. In the remnant adaptive gut, the number of 5-BrdU-labeled cells per crypt was significantly increased by retinoic acid (100 µg but not 18 µg). At 6 h postresection, the ileal crypts of treated rats contained 53% more labeled cells compared with vehicle-treated controls (Fig. 4; retinoic acid mean cells per crypt = 15 vs. vehicle mean = 9.8, P < 0.001). At 6 and 16 h after resection, on the basis of the total number of cells per crypt, expansion of the total crypt cell population had not yet occurred. Thus, 6 h after resection, retinoic acid increased the labeling index (i.e., 5-BrdU-stained crypt cells/total crypt cells) by 50% (from 20 to 30%; P = 0.002 compared with vehicle-treated rats). In contrast to resected rats, retinoic acid did not stimulate intestinal proliferation in rats that did not undergo surgery. In fact, by 6 h after either dose of retinoic acid, the crypt labeling index was reduced by ~6% (data not shown).


Fig. 3. Immunohistochemical detection of 5-bromodeoxyuridine (5-BrdU) incorporation into proliferating ileal crypt cells of rats following intestinal resection and administration of retinoic acid or vehicle. These ileal sections demonstrating 5-BrdU-labeled proliferating crypt cells are representative of the data obtained from examining at least ten well-oriented, longitudinal crypts per segment from 5-9 rats per experimental group. 5 BrdU incorporation was detected using a goat anti-BrdU antibody and CY3 conjugated donkey anti-goat IgG 6 h after intestinal resection and administration of the control vehicle (A) or retinoic acid (100 µg, B), Note the greater number of white 5-BrdU labeled cells in (B). Typical crypts are indicated by arrows.
[View Larger Version of this Image (94K GIF file)]


Fig. 4. Effect of retinoic acid on ileal crypt cell proliferation in rats following 70% small bowel resection. 5-Bromodeoxyuridine (5-BrdU) incorporation into proliferating ileal crypt cells was assessed at 6 and 16 h after resection and administration of retinoic acid (100 µg, RA) or vehicle (Veh). Rats were killed 90 min after being injected with 5-BrdU (8 g/L) and 5-fluorodeoxyuridine (0.8 g/L) combined in sterile water. 5-BrdU was detected with a goat anti-BrdU antibody, and antigen-antibody complexes were labeled using a gold-conjugated rabbit anti-goat secondary antibody with silver enhancement. The number of labeled and unlabeled cells in ten well-oriented, longitudinal crypts per segment from each rat (n = 5-9 rats per experimental group) was counted using light microscopy as described. The basal number of S-phase crypt cells was determined at time 0. Data are presented as the mean ± SEM. *P < 0.001 compared with Veh.
[View Larger Version of this Image (16K GIF file)]

In Figure 4, the number of labeled crypt cells at time 0 reflects the basal proliferation rate before surgery. The increase in the number of 5-BrdU-labeled crypt cells in the resected vehicle control group reflects changes induced by intestinal adaptation alone. By 16 h, there were no significant differences in 5-BrdU labeling between the retinoic acid-treated group and the vehicle-treated group. However, as expected, the labeling index was greater in both groups of resected rats compared with nonresected rats.

CRBP II and apo A-I expression are not augmented by retinoic acid administration after small bowel resection. CRBP II and apo A-I steady-state mRNA levels were not significantly changed in the proximal or distal intestinal segments at 6 or 16 h postresection by either dose of retinoic acid (data not shown). Thus retinoic acid did not independently augment CRBP II mRNA levels above those attributed to intestinal resection alone.

In addition, at 6 h after surgery and retinoic acid administration, there were no differences in steady-state RXR-alpha mRNA levels, whereas, at 16 h, RXR-alpha mRNA levels were decreased 40% (P < 0.05; 100 µg dosage; data not shown). The regulation of RXR-alpha by retinoids has been demonstrated only in F9 teratocarcinoma cells and in the vitamin A-deficient rat testis after readministration of retinyl acetate (van Pelt et al. 1992, Wan et al. 1994). These observations suggest that retinoic acid receptors (RAR) and RXR may help to regulate RXR-alpha expression and underscore the possibility that changes in intestinal gene expression may be influenced by changes in the quantity and type of retinoic acid receptors. In addition, changes in the concentrations and binding of receptor ligands and interactions with other trans acting factors are also important.


DISCUSSION

These studies have provided evidence supporting a role for retinoic acid in the early stages of the intestinal adaptive response. They were initiated because of the established effects of retinoids on the proliferation and differentiation of epithelial tissues and the discovery that CRBP II expression is increased in the remnant ileum by 48 h after 70% small intestinal resection (Dodson et al. 1996).

As discussed above, crypt cell proliferation is enhanced in the adapting remnant intestine following partial resection. The direct effects of vitamin A and retinoic acid on intestinal epithelial proliferation and differentiation have not been reported. Studies using different models for inducing vitamin A deficiency in rats have produced conflicting results. For example, when rats with absent vitamin A stores were maintained on retinoic acid, there were no effects on the rate of division or migration up the villus of intestinal epithelial cells (Rojanapo et al. 1980a). However, using rats in the early stages of vitamin A deficiency (i.e., rats whose weight had plateaued after weaning to a vitamin A- and retinoic acid-deficient diet), there was significant prolongation of the S2-phase of the cell cycle in the jejunal crypts (Zile et al. 1977). In these vitamin A-deficiency models, the morphological appearance of the small intestine was nearly normal except for a quantitative decrease in goblet cells. Thus, these studies have provided indirect evidence supporting a role for retinoids in maintenance of goblet cells (Rojanapo et al. 1980b) but not enterocytes, enteroendocrine cells or Paneth cells.

To assess directly the ability of retinoic acid to modulate crypt cell proliferation in the postresection adapting intestine, crypt cell incorporation of 5-BrdU was assessed. Administration of 100 µg of retinoic acid resulted in a 53% increase in the number of proliferating ileal crypt cells at 6 h after small bowel resection. Thus retinoic acid may have a role in enhancing the intestinal adaptive response. Although our data are compatible with a stimulatory role for retinoic acid in small intestinal epithelial renewal after partial resection, administration of retinoic acid to normal (i.e., nonoperated) rats resulted in a 6% decrease in the crypt labeling index. Thus the stimulatory effects of retinoic acid on crypt cell proliferation may be specific to the adapting intestine or may vary depending on the physiological context.

The intestinal effects of retinoic acid are consistent with those in other epithelial tissues in which it has been shown to modulate cell proliferation and/or differentiation. In vivo demonstrations of retinoid inhibition of cell proliferation and stimulation of differentiation include the use of postnatal retinoic acid to increase the number of pulmonary alveoli in rats (Massaro and Massaro 1996) and the use of retinoids to treat and prevent premalignant and malignant skin lesions [reviewed in Lotan (1996)]. In vitro, retinoids can also have the opposite effect as illustrated by the suppression of terminal differentiation and stimulation of proliferation in cultured keratinocytes [reviewed in Fisher and Voorhees (1996)]. Retinoids are also active in nonepithelial cell types as indicated by differentiative effects on HL60 promyelocytic cells and F9 teratocarcinoma cells and by the successful use of retinoic acid as differentiation therapy in promyelocytic leukemia [reviewed in Chomienne et al. (1996) and Gudas et al. (1994)].

As shown in Figure 4, by 16 h after resection, the number of cells incorporating 5-BrdU was the same whether retinoic acid was or was not administered at the time of surgery. Thus, these studies indicate that the usual increase in ileal crypt cell proliferation after massive small bowel resection can be induced to occur earlier by treatment with retinoic acid. The equalization of the number of labeled cells by 16 h after retinoic acid administration suggests that the acute effect is limited to a discrete population of G1 cells already primed to initiate DNA synthesis. Although these data might suggest that retinoid effects are limited to the immediate postresection period, the quantity and time course of retinoic acid delivery to the intestinal mucosa were not addressed. Pharmacokinetic studies indicate that circulating retinoic acid metabolites but not retinoic acid would still be present by 16 h after either dosage (Swanson et al. 1981). Thus, it will be worthwhile to evaluate whether regular dosing with retinoic acid can further expand the proliferating crypt cell population.

The temporal, spatial and cellular patterns of CRBP II expression after resection were determined as a basis for addressing a potential role for CRBP II in early adaptation. CRBP II mRNA levels in the remnant ileum were increased by 8 h and remained elevated for at least 1 wk postoperatively. In contrast, apo A-I mRNA levels are not increased at 8 h, are maximally increased at 16 h, are back to base line by 24 h and, as previously demonstrated, are still at base line for at least 1 wk after small bowel resection (Rubin et al. 1996). Thus, despite the presence of a common RXR-alpha response element in the promoter of each of these genes, the temporal regulation of apo A-I and CRBP II expression during adaptation is different. This observation underscores the potential importance of other transcription factors. For example, the apo A-I promoter also contains binding sites for the orphan receptors ARP-1, HNF-4, Ear3-COUP-TF and a response element for a peroxisome proliferator-activated receptor [reviewed in Kardassis et al. (1996)]. The CRBP II promoter contains an element that efficiently binds HNF-4 and ARP-1 in vitro (Nakshatri and Chambon 1994). Although the functions of these receptors are not known, all but HNF-4 can form heterodimers with RXR and thus are potentially regulated by retinoids. In addition, peroxisome proliferator-activated receptors are implicated in fatty acid signaling pathways, which could also be important in the adapting intestine. Despite the regulation of CRBP II expression by retinoic acid in Caco-2 cells (Levin and Davis 1997), the potential importance of other regulators of CRBP II expression postresection is underscored by the inability of exogenous retinoic acid to consistently increase CRBP II mRNA above the levels resulting from surgical resection alone. In addition, the fact that retinoic acid administration downregulated RXR-alpha expression by 16 h postresection underscores the possibility that changes in intestinal gene expression may be influenced by variation in the number and type of retinoic acid receptors, along with interactions with other trans acting factors and changes in the concentrations and binding of their ligands.

The sustained increase in CRBP II expression at 1 wk after resection may reflect an adaptive mechanism to increase retinol absorption per unit of small bowel surface area. Such a response would be consistent with our demonstration that CRBP II levels are determinants of vitamin A absorption in Caco-2 cells (Levin 1993, Levin and Davis 1997, Lissoos et al. 1995) and evidence that intestinal CRBP II levels are regulated by physiological stimuli such as lactation (Levin et al. 1987) and vitamin A deficiency (Rajan et al. 1990).

Conversely, the induction of CRBP II expression before 8 h postresection may reflect a regulatory role for retinoids in the early stages of the adaptive response. The normal intestine and the adapting intestinal remnant are likely target tissues for retinoic acid because they are actively proliferating and differentiating epithelial tissues. Furthermore, the small intestine is able to absorb, metabolize and synthesize retinoic acid. Because CRBP II clearly plays an important role in intestinal vitamin A absorption and metabolism [reviewed in Levin (1994)], increases in CRBP II levels in the adapting remnant intestine might directly affect cellular levels of retinoic acid, 9-cis-retinoic acid and other putative ligands of nuclear retinoid receptors. Nevertheless, CRBP II expression remains confined to villus-associated enterocytes postresection, and thus, any regulatory effects deriving from the observed increase in CRBP II expression are probably limited to this cell population.

In conclusion, these studies have shown that retinoic acid can stimulate crypt cell proliferation in the adapting remnant intestine by 6 h after partial small bowel resection. The early and sustained increase in CRBP II expression suggests that CRBP II may have a specific role in mediating the effects of retinoids on the adapting intestine. These observations indicate that retinoids are likely modulators of intestinal adaptation after loss of functional small bowel surface area.


ACKNOWLEDGMENTS

We gratefully acknowledge the assistance of Alan Davis, Katherine Grapperhaus, Elzbieta Swietlicki and Redmond Tudos.


FOOTNOTES

1   Presented in part at Digestive Disease Week, May 1995, San Diego, CA [Wang, J. L., Rubin, D. C. & Levin, M. S. (1995) Retinoic acid modulates intestinal adaptation following 70% resection of the rat proximal small intestine. Gastroenterology 108s: A337 (abs.)].
2   Supported by National Institutes of Health grants DK46122 and DK50466 and the Crohn's and Colitis Foundation of America. J. W. was supported by National Research Service Awards T32 DK07130 and DK09077 and by an American Digestive Health Foundation Astra Merck Advanced Research Training Award. D.S.-B. was supported by National Research Service Award T32 DK07130.
3   The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
4   To whom correspondence should be addressed.
5   Abbreviations used: apo, apolipoprotein; 5-BrdU, 5-bromodeoxyuridine; CRBP II, cellular retinol binding protein type II; RXR-alpha , retinoid-X-receptor-alpha.

Manuscript received 30 July 1996. Initial reviews completed 30 August 1996. Revision accepted 7 March 1997.


LITERATURE CITED


0022-3166/97 $3.00 ©1997 American Society for Nutritional Sciences



This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. Wang, Y. Tang, D. C. Rubin, and M. S. Levin
Chronically administered retinoic acid has trophic effects in the rat small intestine and promotes adaptation in a resection model of short bowel syndrome
Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1559 - G1569.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. H. Tezel, L. Geng, H. J. Kaplan, and L. V. Del Priore
Retinal Pigment Epithelium Rescues Vascular Endothelium from Retinoic Acid-Induced Apoptosis
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 5075 - 5087.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. A. Swartz-Basile, L. Wang, Y. Tang, H. A. Pitt, D. C. Rubin, and M. S. Levin
Vitamin A deficiency inhibits intestinal adaptation by modulating apoptosis, proliferation, and enterocyte migration
Am J Physiol Gastrointest Liver Physiol, July 7, 2003; 285(2): G424 - G432.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. E, L. Zhang, J. Lu, P. Tso, W. S. Blaner, M. S. Levin, and E. Li
Increased Neonatal Mortality in Mice Lacking Cellular Retinol-binding Protein II
J. Biol. Chem., September 20, 2002; 277(39): 36617 - 36623.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. C. Rubin, E. A. Swietlicki, H. Iordanov, C. Fritsch, and M. S. Levin
Novel goblet cell gene related to IgGFcgamma BP is regulated in adapting gut after small bowel resection
Am J Physiol Gastrointest Liver Physiol, November 1, 2000; 279(5): G1003 - G1010.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. C. Rubin, E. A. Swietlicki, J. L. Wang, and M. S. Levin
Regulation of PC4/TIS7 expression in adapting remnant intestine after resection
Am J Physiol Gastrointest Liver Physiol, September 1, 1998; 275(3): G506 - G513.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. Goyal, R. Singh, E. A. Swietlicki, M. S. Levin, and D. C. Rubin
Characterization of rat epimorphin/syntaxin 2 expression suggests a role in crypt-villus morphogenesis
Am J Physiol Gastrointest Liver Physiol, July 1, 1998; 275(1): G114 - G124.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, J. L.
Right arrow Articles by Levin, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, J. L.
Right arrow Articles by Levin, M. S.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]